132 related articles for article (PubMed ID: 18451066)
1. Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas.
Métayé T; Levillain P; Kraimps JL; Perdrisot R
J Endocrinol; 2008 Jul; 198(1):101-10. PubMed ID: 18451066
[TBL] [Abstract][Full Text] [Related]
2. Expression and activity of g protein-coupled receptor kinases in differentiated thyroid carcinoma.
Métayé T; Menet E; Guilhot J; Kraimps JL
J Clin Endocrinol Metab; 2002 Jul; 87(7):3279-86. PubMed ID: 12107237
[TBL] [Abstract][Full Text] [Related]
3. GRK2 and beta-arrestin 1 as negative regulators of thyrotropin receptor-stimulated response.
Iacovelli L; Franchetti R; Masini M; De Blasi A
Mol Endocrinol; 1996 Sep; 10(9):1138-46. PubMed ID: 8885248
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein.
Mizukami Y; Hashimoto T; Nonomura A; Michigishi T; Nakamura S; Noguchi M; Matsukawa S
J Clin Endocrinol Metab; 1994 Aug; 79(2):616-9. PubMed ID: 8045985
[TBL] [Abstract][Full Text] [Related]
5. G-protein-coupled receptor kinase 2 in pancreatic cancer: clinicopathologic and prognostic significance.
Zhou L; Wang MY; Liang ZY; Zhou WX; You L; Pan BJ; Liao Q; Zhao YP
Hum Pathol; 2016 Oct; 56():171-7. PubMed ID: 27346572
[TBL] [Abstract][Full Text] [Related]
6. p66Shc expression in proliferating thyroid cells is regulated by thyrotropin receptor signaling.
Park YJ; Kim TY; Lee SH; Kim H; Kim SW; Shong M; Yoon YK; Cho BY; Park DJ
Endocrinology; 2005 May; 146(5):2473-80. PubMed ID: 15705774
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms.
Clark OH; Gerend PL
Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305
[TBL] [Abstract][Full Text] [Related]
8. Effect of thyroid-stimulating hormone and norepinephrine on cyclic AMP levels in human normal thyroids and human thyroid tumors.
Aiyoshi Y; Yamashita K; Fujimoto Y
Endocrinol Jpn; 1980 Oct; 27(5):625-30. PubMed ID: 6263597
[TBL] [Abstract][Full Text] [Related]
9. SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.
Moraitis D; Karanikou M; Liakou C; Dimas K; Tzimas G; Tseleni-Balafouta S; Patsouris E; Rassidakis GZ; Kouvaraki MA
Surgery; 2014 Dec; 156(6):1542-8; discussion 1548-9. PubMed ID: 25456951
[TBL] [Abstract][Full Text] [Related]
10. Mitogenic effects of thyrotropin and adenosine 3',5'-monophosphate in differentiated normal human thyroid cells in vitro.
Roger P; Taton M; Van Sande J; Dumont JE
J Clin Endocrinol Metab; 1988 Jun; 66(6):1158-65. PubMed ID: 2836470
[TBL] [Abstract][Full Text] [Related]
11. Growth suppression of thyroid cancer cells by adenylcyclase activator.
Yano Y; Kamma H; Matsumoto H; Fujiwara M; Bando H; Hara H; Yashiro T; Ueno E; Ito K; Uchida K
Oncol Rep; 2007 Aug; 18(2):441-5. PubMed ID: 17611668
[TBL] [Abstract][Full Text] [Related]
12. Expression, localization, and thyrotropin regulation of cathepsin D in human thyroid tissues.
Métayé T; Kraimps JL; Goujon JM; Fernandez B; Quellard N; Ingrand P; Barbier J; Bégon F
J Clin Endocrinol Metab; 1997 Oct; 82(10):3383-8. PubMed ID: 9329373
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors.
Hoffmann S; Hofbauer LC; Scharrenbach V; Wunderlich A; Hassan I; Lingelbach S; Zielke A
J Clin Endocrinol Metab; 2004 Dec; 89(12):6139-45. PubMed ID: 15579770
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor receptors as molecular targets in thyroid carcinoma.
St Bernard R; Zheng L; Liu W; Winer D; Asa SL; Ezzat S
Endocrinology; 2005 Mar; 146(3):1145-53. PubMed ID: 15564323
[TBL] [Abstract][Full Text] [Related]
16. Stimulatory effect of vasoactive intestinal polypeptide on human normal and neoplastic thyroid tissue.
Siperstein AE; Miller RA; Clark OH
Surgery; 1988 Dec; 104(6):985-91. PubMed ID: 2848326
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the intact thyrotropin receptor in a human thyroid carcinoma cell line.
Namba H; Yamashita S; Usa T; Kimura H; Yokoyama N; Izumi M; Nagataki S
Endocrinology; 1993 Feb; 132(2):839-45. PubMed ID: 8381075
[TBL] [Abstract][Full Text] [Related]
18. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.
Elisei R; Vivaldi A; Agate L; Ciampi R; Molinaro E; Piampiani P; Romei C; Faviana P; Basolo F; Miccoli P; Capodanno A; Collecchi P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2005 Apr; 90(4):2403-11. PubMed ID: 15623821
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor and thyrotropin response in human thyroid tissues.
Di Carlo A; Mariano A; Pisano G; Parmeggiani U; Beguinot L; Macchia V
J Endocrinol Invest; 1990 Apr; 13(4):293-9. PubMed ID: 2164546
[TBL] [Abstract][Full Text] [Related]
20. Different growth control of the two human thyroid cell lines of adenomatous goiter and papillary carcinoma.
Hishinuma A; Yamanaka T; Kasai K; So S; Tseng CC; Bamba N; Ohtake H; Shimoda S
Thyroid; 1995 Feb; 5(1):41-6. PubMed ID: 7787432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
